MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quirk, K.
Right arrow Articles by McKernan, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quirk, K.
Right arrow Articles by McKernan, R. M.

gamma-Aminobutyric acid type A receptors in the rat brain can contain both gamma 2 and gamma 3 subunits, but gamma 1 does not exist in combination with another gamma subunit

K Quirk, NP Gillard, CI Ragan, PJ Whiting and RM McKernan

Department of Biochemistry, Merck, Sharp, and Dohme Research Laboratories, Harlow, Essex, UK.

Antibodies specific for the gamma 1, gamma 2, and gamma 3 subunits of the gamma-aminobutyric acid (GABA)A receptor have been used to probe the composition of naturally occurring GABAA receptors in the rat brain. Most GABAA receptors contain at least one of these three subunits. The percentage of each, determined by immunoprecipitation of [3H]muscimol binding, was 11 +/- 1%, 59 +/- 3%, and 14 +/- 2% for gamma 1, gamma 2, and gamma 3 subunits, respectively. Receptors containing gamma 2 or gamma 3 subunits were labeled by benzodiazepine site ligands with high affinity, whereas gamma 1-containing receptors could be labeled only by [3H]muscimol. Receptors immunoprecipitated by anti- gamma 2 or anti-gamma 3 antibodies were labeled with [3H]Ro 15-1788 with similar affinities (Kd for anti-gamma 2-immunoprecipitated receptors, 1.9 nM; Kd for anti-gamma 3-immunoprecipitated receptors, 1.7 nM). Immunoprecipitation or Western blot analysis of GABAA receptors solubilized from rat cerebellar or whole-brain preparations indicated that gamma 1 was not present coassembled with any other gamma subunit. Western blot analysis of receptors purified on alpha-specific immunoaffinity resins showed that gamma 1 was predominantly assembled with the alpha 2 subunit. Some GABAA receptors may contain more than one type of gamma subunit. Quantitative immunoprecipitation and Western blot analysis both indicated that gamma 2 and gamma 3 subunits can exist in the same receptor complex. A large proportion of GABAA receptors immunopurified on a gamma 3 affinity resin also appeared to contain a gamma 2 subunit. In contrast, when receptors were purified on a gamma 2 affinity resin a small proportion also appeared to contain a gamma 3 subunit. We conclude that most gamma 1-containing receptors have no other gamma subunit in the same receptor complex but some GABAA receptors contain both gamma 2 and gamma 3 subunits.

Volume 45, Issue 6, pp. 1061-1070, 06/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
R. W. Olsen and W. Sieghart
International Union of Pharmacology. LXX. Subtypes of {gamma}-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Update
Pharmacol. Rev., September 1, 2008; 60(3): 243 - 260.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. W. Baumann, R. Baur, and E. Sigel
Forced Subunit Assembly in alpha 1beta 2gamma 2 GABAA Receptors. INSIGHT INTO THE ABSOLUTE ARRANGEMENT
J. Biol. Chem., November 22, 2002; 277(48): 46020 - 46025.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Sur, K. A. Wafford, D. S. Reynolds, K. L. Hadingham, F. Bromidge, A. Macaulay, N. Collinson, G. O'Meara, O. Howell, R. Newman, et al.
Loss of the Major GABAA Receptor Subtype in the Brain Is Not Lethal in Mice
J. Neurosci., May 15, 2001; 21(10): 3409 - 3418.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. Feigenspan, S. Gustincich, and E. Raviola
Pharmacology of GABAA Receptors of Retinal Dopaminergic Neurons
J Neurophysiol, October 1, 2000; 84(4): 1697 - 1707.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Louiset, R. McKernan, W. Sieghart, and H. Vaudry
Subunit Composition and Pharmacological Characterization of {gamma}-Aminobutyric Acid Type A Receptors in Frog Pituitary Melanotrophs
Endocrinology, March 1, 2000; 141(3): 1083 - 1092.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Gustincich, A. Feigenspan, W. Sieghart, and E. Raviola
Composition of the GABAA Receptors of Retinal Dopaminergic Neurons
J. Neurosci., September 15, 1999; 19(18): 7812 - 7822.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Araujo, D. Ruano, and J. Vitorica
Native gamma -Aminobutyric Acid Type A Receptors from Rat Hippocampus, Containing Both alpha 1 and alpha 5 Subunits, Exhibit a Single Benzodiazepine Binding Site with alpha 5 Pharmacological Properties
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 989 - 997.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. P. Bonnert, R. M. McKernan, S. Farrar, B. le Bourdelles, R. P. Heavens, D. W. Smith, L. Hewson, M. R. Rigby, D. J. S. Sirinathsinghji, N. Brown, et al.
theta , a novel gamma -aminobutyric acid type A receptor subunit
PNAS, August 17, 1999; 96(17): 9891 - 9896.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Farrar, P. J. Whiting, T. P. Bonnert, and R. M. McKernan
Stoichiometry of a Ligand-gated Ion Channel Determined by Fluorescence Energy Transfer
J. Biol. Chem., April 9, 1999; 274(15): 10100 - 10104.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Sur, K. Quirk, D. Dewar, J. Atack, and R. McKernan
Rat and Human Hippocampal alpha 5 Subunit-Containing gamma -Aminobutyric AcidA Receptors Have alpha 5beta 3gamma 2 Pharmacological Characteristics
Mol. Pharmacol., November 1, 1998; 54(5): 928 - 933.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
E. A. Barnard, P. Skolnick, R. W. Olsen, H. Mohler, W. Sieghart, G. Biggio, C. Braestrup, A. N. Bateson, and S. Z. Langer
International Union of Pharmacology. XV. Subtypes of gamma -Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Structure and Receptor Function
Pharmacol. Rev., June 1, 1998; 50(2): 291 - 314.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. B. Wingrove, S. A. Thompson, K. A. Wafford, and P. J. Whiting
Key Amino Acids in the gamma  Subunit of the gamma -Aminobutyric AcidA Receptor that Determine Ligand Binding and Modulation at the Benzodiazepine Site
Mol. Pharmacol., November 1, 1997; 52(5): 874 - 881.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Li and A. L. De Blas
Coexistence of Two beta  Subunit Isoforms in the Same gamma -Aminobutyric Acid Type A Receptor
J. Biol. Chem., June 27, 1997; 272(26): 16564 - 16569.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. Tretter, N. Ehya, K. Fuchs, and W. Sieghart
Stoichiometry and Assembly of a Recombinant GABAA Receptor Subtype
J. Neurosci., April 15, 1997; 17(8): 2728 - 2737.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Araujo, S. Tan, D. Ruano, H. Schoemaker, J. Benavides, and J. Vitorica
Molecular and Pharmacological Characterization of Native Cortical gamma -Aminobutyric AcidA Receptors Containing Both alpha 1 and alpha 3 Subunits
J. Biol. Chem., November 1, 1996; 271(44): 27902 - 27911.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Chang, R. Wang, S. Barot, and D. S. Weiss
Stoichiometry of a Recombinant GABAA Receptor
J. Neurosci., September 1, 1996; 16(17): 5415 - 5424.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics